Study Investigating the Interactions of Bone and Hematopoiesis in the Elderly
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
DNA Hypomethylating Agents and Lenalidomide in Elderly Patients With Myeloid Malignancies in the US
- Status
- WITHDRAWN
- Phase
- N/A
Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy
- Status
- UNKNOWN
- Phase
- PHASE2
A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms
- Status
- COMPLETED
- Phase
- N/A
A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
A Clinical Trial of Omacetaxine, Azacitidine, and Growth-Colony Stimulating Factor (G-CSF) for Myelodysplastic Syndromes (MDS)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Identification of Molecular Defects in Idiopathic Cytopenia of Undetermined Significance
- Status
- TERMINATED
- Phase
- N/A
Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Pevonedistat in Adult East Asian Participants
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of a Question Prompt List for Patients With Myelodysplastic Syndromes (QPL-MDS)
- Status
- UNKNOWN
- Phase
- NA
Tipifarnib in Subjects With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE2
An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Prophylactic Application of Donor-derived TCM After Allogeneic HSCT
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CIK-Cells in Relapsing Patients With Acute Leukemia or Myelodysplastic Syndromes After SCT.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Trial of Volasertib With or Without Azacitidine in Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1
Investigation of the Genetics of Hematologic Diseases
- Status
- RECRUITING
- Phase
- N/A
PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.
- Status
- COMPLETED
- Phase
- NA
Allo HSCT Using RIC for Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2